Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (141-150 of 254) with videos related to

Pageof 26
Sort By:
Molecular and Cellular Endocrinology|August 10, 2016
LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeletonAngel Matias Sanchez, Marina Ines Flamini, Eleonora Russo, et al.
Leukemia Research|August 4, 2004
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocythemiaRita Fazzi, Sara Galimberti, Simone Pacini, et al.
Hematology Reports|January 12, 2019
Morphologic and immunophenotypic features of a case of acute monoblastic leukemia with unusual positivity for Glycophorin-AGiovanni Carulli, Paola Sammuri, Cristiana Domenichini, et al.
Recenti Progressi in Medicina|August 5, 2005
[Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy]Giovanni Carulli, Silvia Canigiani, Maila Volpini, et al.
International Journal of Hematology|May 9, 2015
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric studyGiovanni Carulli, Virginia Ottaviano, Paola Sammuri, et al.
The Lancet. Oncology|August 4, 2009
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectKenneth R Carson, Daniele Focosi, Eugene O Major, et al.
Hematology Reports|October 23, 2012
B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapyGiovanni Carulli, Alessandra Marini, Maria I Ferreri, et al.
British Journal of Haematology|April 3, 2003
Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosisRita Fazzi, Simone Pacini, Rossana Testi, et al.
Anticancer Research|August 21, 2003
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemiaSara Galimberti, Angela Rossi, Giuseppe Alberto Palumbo, et al.
Annals of Hematology|September 4, 2009
Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximabMarco Tuccori, Daniele Focosi, Fabrizio Maggi, et al.
Pageof 26

Showing results (141-150 of 254) with videos related to

Sort By:
Pageof 26
Molecular and Cellular Endocrinology|August 10, 2016
LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeletonAngel Matias Sanchez, Marina Ines Flamini, Eleonora Russo, et al.
Leukemia Research|August 4, 2004
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocythemiaRita Fazzi, Sara Galimberti, Simone Pacini, et al.
Hematology Reports|January 12, 2019
Morphologic and immunophenotypic features of a case of acute monoblastic leukemia with unusual positivity for Glycophorin-AGiovanni Carulli, Paola Sammuri, Cristiana Domenichini, et al.
Recenti Progressi in Medicina|August 5, 2005
[Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy]Giovanni Carulli, Silvia Canigiani, Maila Volpini, et al.
International Journal of Hematology|May 9, 2015
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric studyGiovanni Carulli, Virginia Ottaviano, Paola Sammuri, et al.
The Lancet. Oncology|August 4, 2009
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectKenneth R Carson, Daniele Focosi, Eugene O Major, et al.
Hematology Reports|October 23, 2012
B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapyGiovanni Carulli, Alessandra Marini, Maria I Ferreri, et al.
British Journal of Haematology|April 3, 2003
Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosisRita Fazzi, Simone Pacini, Rossana Testi, et al.
Anticancer Research|August 21, 2003
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemiaSara Galimberti, Angela Rossi, Giuseppe Alberto Palumbo, et al.
Annals of Hematology|September 4, 2009
Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximabMarco Tuccori, Daniele Focosi, Fabrizio Maggi, et al.
Pageof 26